Cover Image
市場調查報告書

Array BioPharma Inc. - 產品平台分析

Array BioPharma Inc - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 224607
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
Array BioPharma Inc. - 產品平台分析 Array BioPharma Inc - Product Pipeline Review - 2016
出版日期: 2016年12月30日 內容資訊: 英文 71 Pages
簡介

Array BioPharma Inc.ha是致力於開發及商品化治療癌症及發炎疾病用標的小分子藥劑的生物製藥公司。

本報告提供Array BioPharma Inc.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Array BioPharma Inc.的基本資料

Array BioPharma Inc.概要

  • 主要資訊
  • 企業資料

Array BioPharma Inc.:R&D概要

  • 主要的治療範圍

Array BioPharma Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Array BioPharma Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式
  • ■Array BioPharma Inc.:藥物簡介
  • ARRY-502
  • ARRY-520
  • ARRY-797
  • ARRY-380
  • ARRY-614
  • AR-460770
  • AR-523
  • AR-786
  • ARRY-005
  • ARRY-006
  • ARRY-111
  • ARRY-981
  • Drugs Targeting Inflammation Pathway
  • Small Molecule To Inhibit B-Raf Kinase For Cancer

Array BioPharma Inc.:開發平台分析

  • 各治療分類
  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Array BioPharma Inc.:最近的開發平台趨勢

Array BioPharma Inc.:暫停中的計劃

Array BioPharma Inc.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • ARRY-797
  • ■Array BioPharma Inc.:企業發表

Array BioPharma Inc.:總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08184CDB

Summary

Global Markets Direct's, 'Array BioPharma Inc - Product Pipeline Review - 2016', provides an overview of the Array BioPharma Inc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Array BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Array BioPharma Inc
  • The report provides overview of Array BioPharma Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Array BioPharma Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Array BioPharma Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Array BioPharma Inc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Array BioPharma Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Array BioPharma Inc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Array BioPharma Inc Snapshot
    • Array BioPharma Inc Overview
    • Key Facts
  • Array BioPharma Inc - Research and Development Overview
    • Key Therapeutic Areas
  • Array BioPharma Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Array BioPharma Inc - Pipeline Products Glance
    • Array BioPharma Inc - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Array BioPharma Inc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Array BioPharma Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Array BioPharma Inc - Drug Profiles
    • AR-00457679 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AR-460770 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AR-523 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AR-786 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-111 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-382 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-797 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-954 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • binimetinib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • binimetinib + encorafenib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • encorafenib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Inflammation - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Array BioPharma Inc - Pipeline Analysis
    • Array BioPharma Inc - Pipeline Products by Target
    • Array BioPharma Inc - Pipeline Products by Route of Administration
    • Array BioPharma Inc - Pipeline Products by Molecule Type
    • Array BioPharma Inc - Pipeline Products by Mechanism of Action
  • Array BioPharma Inc - Dormant Projects
  • Array BioPharma Inc - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ARRY-797
      • AZD-8330
      • binimetinib
      • GDC-0425
      • GDC-0994
      • Mutant cKIT Inhibitor for GIST
      • rabusertib
      • selumetinib sulfate
  • Array BioPharma Inc - Company Statement
  • Array BioPharma Inc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Array BioPharma Inc, Key Facts
  • Array BioPharma Inc - Pipeline by Indication, 2016
  • Array BioPharma Inc - Pipeline by Stage of Development, 2016
  • Array BioPharma Inc - Monotherapy Products in Pipeline, 2016
  • Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016
  • Array BioPharma Inc - Partnered Products in Pipeline, 2016
  • Array BioPharma Inc - Partnered Products/ Combination Treatment Modalities, 2016
  • Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016
  • Array BioPharma Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Array BioPharma Inc - Pre-Registration, 2016
  • Array BioPharma Inc - Phase III, 2016
  • Array BioPharma Inc - Phase II, 2016
  • Array BioPharma Inc - Phase I, 2016
  • Array BioPharma Inc - Preclinical, 2016
  • Array BioPharma Inc - Discovery, 2016
  • Array BioPharma Inc - Pipeline by Target, 2016
  • Array BioPharma Inc - Pipeline by Route of Administration, 2016
  • Array BioPharma Inc - Pipeline by Molecule Type, 2016
  • Array BioPharma Inc - Pipeline Products by Mechanism of Action, 2016
  • Array BioPharma Inc - Dormant Developmental Projects,2016
  • Array BioPharma Inc - Discontinued Pipeline Products, 2016
  • Array BioPharma Inc, Other Locations

List of Figures

  • Array BioPharma Inc - Pipeline by Top 10 Indication, 2016
  • Array BioPharma Inc - Pipeline by Stage of Development, 2016
  • Array BioPharma Inc - Monotherapy Products in Pipeline, 2016
  • Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016
  • Array BioPharma Inc - Partnered Products in Pipeline, 2016
  • Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016
  • Array BioPharma Inc - Pipeline by Top 10 Target, 2016
  • Array BioPharma Inc - Pipeline Route of Administration, 2016
  • Array BioPharma Inc - Pipeline by Molecule Type, 2016
  • Array BioPharma Inc - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top